This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Despite the crucial role of Chest pain centers (CPCs) in acute myocardialinfarction (AMI) management, China's mortality rate for ST-segment elevation myocardialinfarction (STEMI) has remained stagnant. The cohort was stratified by Killip classification at admission (Class 1: n = 402, Class ≥2: n = 262).
Pretreatment with an oral P2Y12 receptor blocker (before coronary angiography) vs. treatment in the catheterizationlaboratory has been a matter of debate in patients presenting with non-ST segment elevation myocardialinfarction (NSTEMI).
Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardialinfarction (AMI). Blood samples were collected in the catheterizationlaboratory during initial percutaneous coronary intervention.
Smith Background : A previous study found that reciprocal ST depression (rSTD) is present in only 82% of inferior ST elevation (STE) acute myocardialinfarction (MI). Methods : We searched the catheterizationlaboratory database for all cases coded as acute Inferior STEMI from January 2002 through March 2008.
The new trial, called DanGer Shock , is the first trial powered to examine whether the use of micro-axial flow pumps can improve survival in ST-elevation myocardialinfarctions (STEMI, the most serious type of heart attack) that are complicated by cardiogenic shock. Among 355 patients who were included in the analysis, 58.5%
ST elevation: differentiation between ST elevation myocardialinfarction and nonischemic ST elevation. Electrocardiographic manifestations: patterns that confound the EKG diagnosis of acute myocardialinfarction—left bundle branch block, ventricular paced rhythm, and left ventricular hypertrophy1. J Electrocardiol.
When one of these arteries becomes completely blocked by a blood clot, it results in a heart attack, also known as MI (Myocardialinfarction). When a person experiences a heart attack or myocardialinfarction, they may feel chest pain and other symptoms in different parts of their body.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
59 
Let's personalize your content